| US 7,592,342 B2 | ||
| Quinoxaline derivatives as PI3 kinase inhibitors | ||
| Yanhong Feng, Collegeville, Pa. (US); Cynthia A. Parrish, Collegeville, Pa. (US); Martha A Sarpong, Collegeville, Pa. (US); and Domingos J Silva, Collegeville, Calif. (US) | ||
| Assigned to SmithKline Beecham Corporation, Philadelphia, Pa. (US) | ||
| Filed on May 08, 2008, as Appl. No. 12/117,127. | ||
| Claims priority of provisional application 60/917120, filed on May 10, 2007. | ||
| Prior Publication US 2008/0293706 A1, Nov. 27, 2008 | ||
| Int. Cl. A61K 31/498 (2006.01) | ||
| U.S. Cl. 514—249 [544/353] | 14 Claims |
1. A compound of Formula (I)(P):
 R2 is optionally substituted 4-pyrazolyl;
each R5 is independently selected from: halogen, acyl, amino, C1-C6alkyl and alkoxy;
m is 0-1;
R6 is —NHSO2R80, wherein R80 is aryl optionally substituted with one to five groups selected from the group consisting of: C1-C6alkyl,
C3-C7cycloalkyl, halogen, amino, substituted amino, trifluoromethyl, cyano, hydroxyl, alkoxy and —(CH2)nCOOH, in which n is 0-2;
or a pharmaceutically acceptable salt thereof.
|